These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9645897)

  • 61. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 62. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
    Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The impact of pre-primary percutaneous coronary intervention β blocker use on the no-reflow phenomenon in patients with acute myocardial infarction].
    Wang J; Chen Y; Wang C; Zhu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):822-6. PubMed ID: 25547444
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical outcomes with beta-blockers in stable patients undergoing percutaneous coronary intervention with adequate left ventricular ejection function].
    Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(45):3666-3671. PubMed ID: 30526776
    [No Abstract]   [Full Text] [Related]  

  • 67. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 68. β-blocker dosage and outcomes after acute coronary syndrome.
    Allen JE; Knight S; McCubrey RO; Bair T; Muhlestein JB; Goldberger JJ; Anderson JL
    Am Heart J; 2017 Feb; 184():26-36. PubMed ID: 27892884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
    Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
    Meurice T; Tricot O; Lemesle G; Deneve M; Lejeune P; Biausque F; Cordier C; Savoye C; Hennebert O; Taghipour K; Sivery B; Pruvost P; Alaoui M; Carpentier L; Segrestin B; Lamblin N; Bauters C
    Arch Cardiovasc Dis; 2015; 108(6-7):340-6. PubMed ID: 25858539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heart rate variables in the Vascular Quality Initiative are not reliable predictors of adverse cardiac outcomes or mortality after major elective vascular surgery.
    Scali S; Bertges D; Neal D; Patel V; Eldrup-Jorgensen J; Cronenwett J; Beck A
    J Vasc Surg; 2015 Sep; 62(3):710-20.e9. PubMed ID: 26067200
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
    Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association between perioperative β-blocker use and clinical outcome of non-cardiac surgery in coronary revascularized patients without severe ventricular dysfunction or heart failure.
    Park J; Kim J; Kwon JH; Park SJ; Min JJ; Lee SM; Gwon HC; Lee YT; Park M; Lee SH
    PLoS One; 2018; 13(8):e0201311. PubMed ID: 30067841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
    Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
    EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study Group.
    Harpaz D; Benderly M; Goldbourt U; Kishon Y; Behar S
    Am J Cardiol; 1996 Dec; 78(11):1215-9. PubMed ID: 8960577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction.
    Hirschl MM; Wollmann CG; Erhart F; Brunner W; Pfeffel F; Gattermeier M; Steger F; Mayr H
    Crit Care Med; 2013 Jun; 41(6):1396-404. PubMed ID: 23528803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
    Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events.
    Emery M; López-Sendón J; Steg PG; Anderson FA; Dabbous OH; Scheuble A; Eagle KA;
    Am Heart J; 2006 Dec; 152(6):1015-21. PubMed ID: 17161045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.